Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06066502 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Precision Ventilation vs Standard Care for Acute Respiratory Distress Syndrome

Study acronym: PREVENT VILI
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion pushed from Oct 1, 2029 to Jul 1, 2030 Completion pushed from Aug 31, 2030 to Dec 31, 2030v8 Show 1 more changeShow less
    • Completion pushed from Aug 31, 2030 to Dec 31, 2030
  2. Study sites: 24 to 33 Eligibility criteria shortened, about 35 words · Secondary endpoints: details revised at 4 of 4 entries · Study description shortened, about 12 wordsv7 Show 3 more changesShow less
    • Eligibility criteria shortened, about 35 words
    • Secondary endpoints: details revised at 4 of 4 entries
    • Study description shortened, about 12 words

    See this version in full on ClinicalTrials.gov ↗

  3. Study sites: 18 to 24 Eligibility criteria expanded, about 160 wordsv6 Show 1 more changeShow less
    • Eligibility criteria expanded, about 160 words

    See this version in full on ClinicalTrials.gov ↗

  4. Study sites: 2 to 18 Collaborators revised (3)v5 Show 1 more changeShow less
    • Collaborators revised (3)

    See this version in full on ClinicalTrials.gov ↗

  5. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Apr 1, 2024 to Jun 24, 2024 · Eligibility criteria expanded, about 50 words · Secondary endpoints: 8 to 4 · 1 morev4 Show 4 more changesShow less
    • Start date changed from estimate of Apr 1, 2024 to Jun 24, 2024
    • Eligibility criteria expanded, about 50 words
    • Secondary endpoints: 8 to 4
    • Site details revised at 2 of 2 sites

    See this version in full on ClinicalTrials.gov ↗

Show 2 earlier versionsHide 2 earlier versions
  1. Start date: Jan 1, 2024 to Apr 1, 2024v3
  2. Secondary endpoints revised (8) Study title shortened, about 4 wordsv2 Show 1 more changeShow less
    • Study title shortened, about 4 words

    See this version in full on ClinicalTrials.gov ↗

  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this interventional study is to compare standard mechanical ventilation to a lung-stress oriented ventilation strategy in patients with Acute Respiratory Distress Syndrome (ARDS). Participants will be ventilated according to one of two different strategies. The main question the study hopes to answer is whether the personalized ventilation strategy helps improve survival.
Trial Details
NCT Number NCT06066502
Lead Sponsor Beth Israel Deaconess Medical Center
Collaborators: NYU Langone Health, Massachusetts General Hospital, National Heart, Lung, and Blood Institute (NHLBI)
Conditions Acute Respiratory Distress Syndrome, Respiratory Failure
Enrollment 1,100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov